Just reported
From Zimmer Biomet's results release of 4 novembre 2026; its quarterly report has since been filed.
Actual
2,06B $US
+3,1 % y/y
-5,2 % q/q
Guided
—
No guide given
Actual
1,00 $US
-14 % y/y
-2,9 % q/q
Guided
—
No guide given
Actual
307,6M $US
-12 % y/y
-5,7 % q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →The themes Zimmer Biomet is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Les parts du chiffre d'affaires sont des estimations pour six months ended June 30, 2026, pas des chiffres tirés d'un document officiel.
Knee replacement implants
Artificial parts that replace all or part of a damaged knee, including components used in later repair or replacement procedures.
Hip replacement systems
Artificial parts that replace the ball and socket of the hip; some are fixed with bone cement and others are designed to attach directly to bone.
Sports medicine, extremities and trauma devices
Devices used to repair soft-tissue injuries, stabilize broken bones, and treat conditions in the foot, ankle, shoulder, elbow and wrist.
ROSA Robot
A surgical robot that helps surgeons position implants during certain knee, hip and shoulder procedures.
ZBEdge
A group of robotic and digital technologies that gathers information before, during and after surgery to help inform patient care.
Bone cement
Cement and related mixing and delivery products used to attach some orthopedic implants to bone.
Zimmer Biomet makes artificial knees and hips, as well as devices used to repair injuries to bones, joints, and surrounding soft tissue. Surgeons use its ROSA robot to help position implants during some operations. Hospitals and surgery centers buy products directly or through distributors and dealers; many products are kept on consignment for use when a procedure is scheduled.
Construit à partir des documents déposés par Zimmer Biomet Holdings, Inc. auprès de la Securities and Exchange Commission (SEC), le gendarme boursier américain. Les chiffres sont tels que publiés, l’historique par action étant retraité sur la base d’actions d’aujourd’hui. Ceci décrit une entreprise — ce n’est pas un conseil en investissement ni une recommandation d’acheter ou de vendre.
103,19 $US-1,4 %clôture 13 nov.
Chiffres jusqu’au 30 septembre 2026, issus du 10-Q déposé le 4 novembre 2026
Zimmer Biomet sells knee and hip replacement implants and other devices for bone and joint surgery to hospitals, surgery centers, and surgeons.
Grade B
La bande sous le cours montre la note à chaque date, établie uniquement à partir des documents publics à ce moment-là.
Affichage de 2 trimestres sur 41 de l’historique des notes de Zimmer Biomet Holdings, Inc.. Les 39 autres remontent jusqu’à novembre 2016.